Continuous Improvement and the Expansion of Quality ... - NCQA

Recommendations

Info

T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • R E f E R E N C E S MEdICal assIstanCE WItH sMokIng and tobaCCo usE CEssatIon 1. Centers for Disease Control and Prevention. 2008. Smoking Attributable Mortality, years of Potential life lost, and Productivity losses— United States, 2000-2004. MMWR 57(45): 1226–228. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm#tab 2. Centers for Disease Control and Prevention. behavioral Risk factor Surveillance System: Nationwide 2009 Data. Adults Who Are Current Smokers. http://apps.nccd.cdc.gov/brfss/page.asp?cat=TU&yr=2009&state=Ub#TU (May 2011) 3. office of the Surgeon General. 2004. The Health Consequences of Smoking: A Report of the Surgeon General. Department of Health and Human Services. Updated 2004. http://www.cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/index.htm (March 17, 2010) 4. American lung Association. General Smoking Facts. Updated february 2010 http://www.lungusa.org/stop-smoking/about-smoking/ facts-figures/general-smoking-facts.html (May 2011) 5. Pierce, J.P., k. Messer, M.M. White, D.W. Cowling, D.P. Thomas. 2011. Prevalence of Heavy Smoking in California and the United States, 1965-2007. JAMA 305(20): 2037–130. 6. Connolly, G.N., H.R. Alpert. 2008. Trends in the Use of Cigarettes and other Tobacco Products, 2000–2007. JAMA 299(22):2629–30. 7. American lung Association. Tobacco Policy Trend Report. Helping Smoker Quit: State Cessation Coverage. Updated february 2009. http://www.lungusa.org/stop-smoking/tobacco-control-advocacy/reports-resources/tobacco-policy-trend-reports/ (May 2011) 8. fiore, M.C., C.R. Jaen, W.C. bailey. Clinical Practice Guideline. Treating Tobacco Use and Dependence: 2008. Update. US Department of Health and Human Services. Updated 2008. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf (March 17, 2010) 9. Maciosek, M.V., A.b. Coffield, N.M. Edwards, T.J. flottemesch, M.J. Goodman, l.I. Solberg. 2006. Priorities among effective clinical preventive services. Results of a systemic review and analysis. Am J Prev Med 31(1):52–61. 10. Tobacco Cessation leadership Network. Trends in Delivery and Reimbursement of Tobacco Dependence Treatment. Updated 2006. http://www.tcln.org/reports/pdfs/Trends_in_Delivery_and_Reimbursement_final.pdf (May 2011) 11. Steinberg, M.b., A. Akincigil, C.D. Delnevo, S. Crystal, J. l. Carson. 2006. Gender and Age Disparities for Smoking-Cessation Treatment. American Journal of Preventive Medicine, 30(5): 405–12. 12. Centers for Disease Control and Prevention. 2005. Annual smoking-attributable mortality, years of potential life lost, and productively losses—United States, 1997–2000. MMWR 54(25):625–8. aMbulatory CarE: EMErgEnCy dEPartMEnt vIsIts 1. Carlo, M.E., J.S. Powers. 2010. Ambulatory Care Sensitive Emergency Department Use Among low-cost Medical Home Patients. Tenn Med. 103(1): 31–3. 2. Centers for Disease Control and Prevention. National Health Statistics Report—National Hospital Ambulatory Medical Care Survey: 2007 Emergency Department Summary. http://www.cdc.gov/nchs/data/nhsr/nhsr026.pdf (June 2011) 3. Institute for Healthcare Improvement. Primary Care Access. http://www.ihi.org/IHI/Topics/officePractices/Access/ (June 2011) 4. Institute of Medicine. 2003. The Future of Emergency Care in the United States Health System. 5. American Hospital Association. 2007. The 2007 State of America’s Hospitals—Taking the Pulse: Finding from the 2007 AHA Survey of Hospital Leaders. www.aha.org/aha/content/2007/PowerPoint/StateofHospitalsChartPack2007.ppt (June 2011) 6. Trzeciak, S., E.P. Rivers. 2003. Emergency Department overcrowding in the United States: An Emerging Threat to Patient Safety and Public Health. Emergency Med J. 20(5): 402–5. 7. bourdreauz, E.D., J. friedman, M.E. Chansky, b.M. baumann. 2004. Emergency Department Patient Satisfaction: Examining the Role of Acuity. Academy of Emergency Medicine. 11(2): 162–8. PErsIstEnCE of bEta-bloCkEr trEatMEnt aftEr a HEart attaCk 1. Mayo Clinic. Heart Attack basics. http://www.mayoclinic.com/health/heart-attack/DS00094 (June 2011) 2. Centers for Disease Control and Prevention. Heart Disease Facts. Updated 2010. http://www.cdc.gov/heartdisease/facts.htm (May 2011) 3. bangalore, S., f.H. Messerli, J.b. kostis, C.J. Pepine. 2007. Cardiovascular Protection Using beta-blockers: A Critical Review of the Evidence. Journal of the American College of Cardiologists 50: 563–72. 4. American Heart Association. 2006. Heart Disease and Stroke Statistics- 2011 Update. http://circ.ahajournals.org/cgi/content/ full/123/4/e18 (May 2011) 5. bradford, W.D., J. Chen, H. M. krumholz. 1999. Under-utilization of beta-blocker After Acute Myocardial Infarction: Pharmacoeconomic Implications. Pharmacoeconomics 15(3): 257–68. 6. Mayo Clinic. 2010. Beta-Blockers. http://www.mayoclinic.com/health/beta-blockers/HI00059 (May 2011) 7. Hernandez, A. f., et al. 2009. Clinical Effectiveness of beta-blockers in Heart failure: findings from the oPTIMIzE-Hf (organized Program to Initiate lifesaving Treatment in Hospitalized Patients with Heart failure) Registry. Journal of American College of Cardiology 53: 184–92. 8. kramer, J.M., et al., 2006. Nation Evaluation of Adherence to beta-blocker Therapy for 1 year After Acute Myocardial Infarction in Patients With Commercial Health Insurance. American Heart Journal 152: 454.1e–454.8e. 9. Ho, P.M., et al., 2006. Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction. Archive of Internal Medicine 166: 1842–47. 10. Phillips, k.A., M.G. Shlipk, P. Coxson, P.A. Heidenreich, M.G. Hunink, P.A. Goldman, et al., 2000. Health and Economic benefits of Increased beta-blocker Use following Myocardial Infarction. JAMA 284(21): 2748–54. 187
188 N AT I o N A l C o M M I T T E E f o R Q U A l I T y A S S U R A N C E 11. The Commonwealth fund. Heart Treatment is the Hospital. Updated 2006. http://www.commonwealthfund.org/Content/Performance- Snapshots/Hospital-Treatment/Heart-Attack-Treatment-in-the-Hospital.aspx (May 2010) 12. levy, C.R., T.A. Radcliff, E.H. Williams, E. Hutt. January 2009. Acute Myocardial Infarction in Nursing Home Residents: Adherence to Treatment Guidelines Reduces Mortality, but Why is Adherence So low? Journal of the American Medical Directors Association; 10(1): 56–61. CoMPrEHEnsIvE dIabEtEs CarE 1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011. pdf (June 2011) 2. American Heart Association. Heart Disease and Stroke Statistics—2011 Update: A Report from the American Heart Association. http://circ.ahajournals.org/cgi/content/full/123/4/e18 (June 2011) 3. National Institute of Diabetes and Digestive and kidney Diseases. Kidney Disease of Diabetes. http://kidney.niddk.nih.gov/kudiseases/ pubs/kdd/index.htm#1 (June 2011) 4. Vermeer S.E., W. Sandee, A. Algra, P.J. koudstaal, l.J. kappelle, D.W. Dippel. 2006. Dutch TIA Trial Study Group. Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients with Transient Ischemic Attack or Minor Ischemic Stroke. Stroke; 37:1413–1417. 5. Centers for Disease Control and Prevention. September 2009. Number (in Thousands) of Hospital Discharges with Diabetes As Any-Listed Diagnosis, United States, 1980-2006. http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm (June 2011) 6. Agency for Healthcare Research and Quality. 2009. HCUP Nationwide Inpatient Sample. http://hcupnet.ahrq.gov/HCUPnet.jsp (June 2011) 7. Asche, C., J. lafleur, C. Conner. 2011 A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic outcomes. Clinical Therapeutics; 33(1): 74–109. 8. Anderson, R.T., k.M. Narayan, et al., April 2011. Effect of Intensive Glycemic lowering on Health-related Quality of life in Type 2 Diabetes: ACCoRD Trial. Diabetes Care; 34(4): 807–12. 9. Saatci, E., G. Tahmiscioglu, N. bozdemir, et al., July 2010. The Well-being and Treatment Satisfaction of Diabetic patients in Primary Care. Health Quality of Life Outcomes; 8:67. ControllIng HIgH blood PrEssurE 1. Mayo Clinic. High Blood Pressure (Hypertension). http://www.mayoclinic.com/health/high-blood-pressure/DS00100 (June 2011) 2. American Heart Association. December 15, 2010. Heart Disease and Stroke Statistics 2011 Update: A Report from the American Heart Association. Circulation: Journal of the American Heart Association http://circ.ahajournals.org/cgi/reprint/CIR.0b013e3182009701 (June 1, 2011) 3. Wang, T.J., and R.S. Vasan. 2005. Epidemiology of Uncontrolled Hypertension in the United States. Circulation 112(11):1651–62. 4. Seshadri, S., A. beiser, M. kelly-Hayes, C.S. kase, R. Au, W.b. kannel, et al. 2006. The lifetime Risk of Stroke: Estimates from the framingham Study. Stroke 37(2):345–50. 5. Vasan, R.S., A. beiser, S. Seshadri, M.G. larson, W.b. kannel, R.b. D’Agostino, D. levy. 2002. Residual lifetime risk for developing hypertension in middle-aged women and men: the framingham Heart Study. JAMA 287:1003–10. 6. Nguyen, Q.C., J.W. Tabor, P.P. Entzel, y. lau, C. Suchindran, J.M. Hussey, C.T. Halpern, k.M. Harris, E.A.Whitsel. May 23, 2011. Discordance in National Estimates of Hypertension Among young Adults. Epidemiology. 7. Vasan, R.S., A. beiser, S. Seshadri, M.G. larson, W.b. kannel, R.b. D’Agostino, D. levy. 2002. Residual lifetime risk for developing hypertension in middle-aged women and men: the framingham Heart Study. JAMA 287:1003–10. 8. Schappert, S.M., E.A. Rechsteiner. 2008. Ambulatory Medical Care Utilization Estimates. National Health Statistics Report, 6:1–29. 9. franco, o.H., A. Peeters, l. bonneux, C. de laet. 2005. blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 46(2):280–6. 10. Whelton, P.k., J. He, l.J. Appel, J.A. Cutler, S. Havas, T.A. kotchen, et al. 2002. Primary Prevention of Hypertension: Clinical and Public Health Advisory from The National High blood Pressure Education Program. JAMA 288:1882–8. 11. Egan, b.M., y. Whoa, R. N. Axon. 2010. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008. Journal of the American Medical Association, 303(20): 2043–50. 12. Centers for Disease Control and Prevention. 2010. Health, United States, 2010: With Special Features of Death and Dying. http://www.cdc.gov/nchs/data/hus/hus10.pdf#066 (June 2011) CHolEstErol ManagEMEnt for PatIEnts WItH CardIovasCular CondItIons 1. Mayo Clinic. 2011. High Cholesterol Basics. http://www.mayoclinic.com/health/high-blood-cholesterol/DS00178/ DSECTIoN=symptoms (June 2011) 2. Centers for Disease Control and Prevention. 2010. Cholesterol. http://www.cdc.gov/cholesterol/about.htm (June 2011) 3. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 2011. Heart Disease and Stroke Statistics—2011 Update. Circulation; 123(4), e18. http://circ.ahajournals.org/cgi/reprint/CIR.0b013e3182009701 (June 2011) 4. Centers for Disease Control and Prevention. 2011. Leading Causes of Death. http://www.cdc.gov/nchs/fastats/lcod.htm (June 2011)
Page 1 and 2:
Continuous Improvement and the Expa
Page 3 and 4:
2 This Report and the data containe
Page 5 and 6:
4 N AT I o N A l C o M M I T T E E
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
top 10 and bottom 10 states “loca
Page 15 and 16:
Page 17 and 18:
16 this measure has shown steady ga
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
24 HEDIS MEASURES of CARE about HEd
Page 27 and 28:
S A f E T y A N D P o T E N T I A l
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
W E l l N E S S A N D P R E V E N T
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
C H R o N I C D I S E A S E M A N A
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
M E A S U R E S T A R G E T E D A T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
C o N S U M E R A N D P A T I E N T
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
128 N AT I o N A l C o M M I T T E
Page 131 and 132:
130 APPENDIx 1: HEDIS EffECTIVENESS
Page 133 and 134:
132 N AT I o N A l C o M M I T T E
Page 135 and 136:
134 APPENDIx 2: HEDIS EffECTIVENESS
Page 137 and 138: 136 N AT I o N A l C o M M I T T E
Page 143 and 144: 142 APPENDIx 4b: ACCREDITED VS. NoN
Page 149 and 150: 148 APPENDIx 6A: ACCREDITED VS. NoN
Page 151 and 152: 150 APPENDIx 6b: ACCREDITED VS. NoN
Page 153 and 154: 152 APPENDIx 7A: PUblICly REPoRTING
Page 159 and 160: 158 APPENDIx 8: PUblICly REPoRTING
Page 173 and 174: 172 MEASURE N AT I o N A l C o M M
Page 175 and 176: 174 APPENDIx 14b: VARIATIoN IN PlAN
Page 181 and 182: 180 APPENDIx 16A: VARIATIoN IN PlAN
Page 183 and 184: 182 APPENDIx 16b: VARIATIoN IN PlAN
Page 185 and 186: 184 REfERENCES N AT I o N A l C o M
Page 187: 186 N AT I o N A l C o M M I T T E
Page 200 and 201: ACkNoWlEDGMENTS Health Plans The 20
show all

Continuous Improvement and the Expansion of Quality ... - NCQA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?